Genetics of schizophrenia from a clinicial perspective

References

• Ahmad, Y., Bhatia, M.S., Mediratta, P.K., Sharma, K.K., Negi, H., Chosdol, K. & Sinha, S. (2009). Association between the ionotropic glutamate receptor kainate3 (GRIK3) Ser310Ala polymorphism and schizophrenia in the Indian population. World Journal of Biological Psychiatry, 10, 330–333.
   PubMed Web of Science ®Google Scholar
• Alkelai, A., Kohn, Y., Olender, T., Sarner-Kanyas, K., Rigbi, A., Hamdan, A., Lerer, B. (2009). Evidence for an interaction of schizophrenia susceptibility loci on chromosome 6q23.3 and 10q24.33-q26.13 in Arab Israeli families. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 150B, 914–925.
   PubMed Web of Science ®Google Scholar
• Allan, C.L., Cardno, A.G. & McGuffin, P. (2008). Schizophrenia: From genes to phenes to disease. Current Psychiatry Reports, 10, 339–343.
   PubMedGoogle Scholar
• Almoguera, B., Riveiro-Alvarez, R., Lopez-Castroman, J., Dorado, P., Vaquero-Lorenzo, C., Fernandez-Piqueras, J., Ayuso, C. (2012). Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population. Pharmacogenomics Journal, doi: 10.1038/tpj.2011.57.
   PubMed Web of Science ®Google Scholar
• Araga, U.S. & Narasu, M.L. (2002). Association between the 102T/C polymorphism of serotonin-2A receptor gene and schizophrenia among south Indians. Molecular Psychiatry, 7, 540–541.
   PubMed Web of Science ®Google Scholar
• Archer, T., Beninger, R.J., Palomo, T. & Kostrzewa, R.M. (2010). Epigenetics and biomarkers in the staging of neuropsychiatric disorders. Neurotoxicity Research, 18, 347–366.
   PubMed Web of Science ®Google Scholar
• Arranz, M.J., Munro, J., Sham, P., Kirov, G., Murray, R.M., Collier, D.A. & Kerwin, R.W. (1998). Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response. Schizophrenia Research, 32, 93–99.
   PubMed Web of Science ®Google Scholar
• Austin, J.C. & Peay, H.L. (2006). Applications and limitations of empiric data in provision of recurrence risks for schizophrenia: A practical review for healthcare professionals providing clinical psychiatric genetics consultations. Clinical Genetics, 70, 177–187.
   PubMed Web of Science ®Google Scholar
• Ayalew, M., Le-Niculescu, H., Levey, D.F., Jain, N., Changala, B., Patel, S.D., ...Niculescu, A.B. (2012). Convergent functional genomics of schizophrenia: From comprehensive understanding to genetic risk prediction. Molecular Psychiatry, doi: 10.1038/mp.2012.37.
   Web of Science ®Google Scholar
• Badner, J.A. & Gershon, E.S. (2002). Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Molecular Psychiatry, 7, 405–411.
   PubMed Web of Science ®Google Scholar
• Banerjee, A., Macdonald, M.L., Borgmann-Winter, K.E. & Hahn, C.G. (2010). Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome. Brain Research Bulletin, 83, 132–139.
   PubMed Web of Science ®Google Scholar
• Barch, D.M. & Ceaser, A. (2012). Cognition in schizophrenia: Core psychological and neural mechanisms. Trends in Cognitive Sciences, 16, 27–34.
   PubMed Web of Science ®Google Scholar
• Benzel, I., Bansal, A., Browning, B.L., Galwey, N.W., Maycox, P.R., McGinnis, R., Purvis, I. (2007). Interactions among genes in the ErbB-neuregulin signalling network are associated with increased susceptibility to schizophrenia. Behavioral and Brain Functions, 3, 31.
   PubMed Web of Science ®Google Scholar
• Blackwood, D.H., Fordyce, A., Walker, M.T., St Clair, D.M., Porteous, D.J. & Muir, W.J. (2001). Schizophrenia and affective disorders—cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. American Journal of Human Genetics, 69, 428–433.
   PubMed Web of Science ®Google Scholar
• Brown, A.S. & Derkits, E.J. (2010). Prenatal infection and schizophrenia: A review of epidemiologic and translational studies. American Journal of Psychiatry, 167, 261–280.
   PubMed Web of Science ®Google Scholar
• Brown, A.S. & Patterson, P.H. (2011). Maternal infection and schizophrenia: Implications for prevention. Schizophrenia Bulletin, 37, 284–290.
   PubMed Web of Science ®Google Scholar
• Camargo, L.M., Collura, V., Rain, J.C., Mizuguchi, K., Hermjakob, H., Kerrien, S., Brandon, N.J. (2007). Disrupted in schizophrenia 1 interactome: Evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Molecular Psychiatry, 12, 74–86.
   PubMed Web of Science ®Google Scholar
• Camargo, L.M., Wang, Q. & Brandon, N.J. (2008). What can we learn from the disrupted in schizophrenia 1 interactome: Lessons for target identification and disease biology?Novartis Foundation Symposium, 289, 208–216; discussion 216–221, 238–240.
   PubMedGoogle Scholar
• Carlsson, A., Waters, N., Holm-Waters, S., Tedroff, J., Nilsson, M. & Carlsson, M.L. (2001). Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence. Annual Review of Pharmacology and Toxicology, 41, 237–260.
   PubMed Web of Science ®Google Scholar
• Carter, C.J. (2009). Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: Cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii. Schizophrenia Bulletin, 35, 1163–1182.
   PubMed Web of Science ®Google Scholar
• Carter, C.J. (2011). Schizophrenia: A pathogenetic autoimmune disease caused by viruses and pathogens and dependent on genes. Journal of Pathogens, doi:10.4061/2011/128318.
   PubMedGoogle Scholar
• Carter, J.W., Schulsinger, F., Parnas, J., Cannon, T. & Mednick, S.A. (2002). A multivariate prediction model of schizophrenia. Schizophrenia Bulletin, 28, 649–682.
   PubMed Web of Science ®Google Scholar
• Chakravarti, A. & Little, P. (2003). Nature, nurture and human disease. Nature, 421, 412–414.
   PubMed Web of Science ®Google Scholar
• Chen, J., Lee, G., Fanous, A.H., Zhao, Z., Jia, P., O'Neill, A., Chen, X. (2011a). Two non-synonymous markers in PTPN21, identified by genome-wide association study data-mining and replication, are associated with schizophrenia. Schizophrenia Research, 131, 43–51.
   PubMed Web of Science ®Google Scholar
• Chen, P., Chen, J., Huang, K., Ji, W., Wang, T., Li, T., … Shi, Y. (2011b). Analysis of association between common SNPs in ErbB4 and bipolar affective disorder, major depressive disorder and schizophrenia in the Han Chinese population. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 36, 17–21.
   PubMed Web of Science ®Google Scholar
• Chen, X., Lee, G., Maher, B.S., Fanous, A.H., Chen, J., Zhao, Z., Kendler, K.S. (2011c). GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Molecular Psychiatry, 16, 1117–1129.
   PubMed Web of Science ®Google Scholar
• Chowdari, K.V., Brandstaetter, B., Semwal, P., Bhatia, T., Deshpande, S., Reddy, R., … Nimgaonkar, V.L. (2001). Association studies of cytosolic phospholipase A2 polymorphisms and schizophrenia among two independent family-based samples. Psychiatric Genetics, 11, 207–212.
   PubMed Web of Science ®Google Scholar
• Chowdari, K.V., Mirnics, K., Semwal, P., Wood, J., Lawrence, E., Bhatia, T., Nimgaonkar, V.L. (2002). Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Human Molecular Genetics, 11, 1373–1380.
   PubMed Web of Science ®Google Scholar
• Clark S.L., Adkins D.E., van den Oord E.J. (2011). Analysis of efficacy and side effects in CATIE demonstrates drug response subgroups and potential for personalized medicine. Schizophrenia Research. 132, 114–120.
   PubMed Web of Science ®Google Scholar
• Corvin, A.P. (2011). Two patients walk into a clinic A genomics perspective on the future of schizophrenia. BioMed Central Biology, 9, 77.
   Google Scholar
• Costa, E., Chen, Y., Davis, J., Dong, E., Noh, J.S., Tremolizzo, L., Guidotti, A. (2002). REELIN and schizophrenia: A disease at the interface of the genome and the epigenome. Molecular Interventions, 2, 47–57.
   PubMedGoogle Scholar
• Debnath, M. & Chaudhuri, T.K. (2006). The role of HLA-G in cytokine homeostasis during early pregnancy complicated with maternal infections: A novel etiopathological approach to the neurodevelopmental understanding of schizophrenia. Medical Hypotheses, 66, 286–293.
   PubMed Web of Science ®Google Scholar
• DeLisi, L.E. & Bertisch, H. (2006). A preliminary comparison of the hopes of researchers, clinicians, and families for the future ethical use of genetic findings on schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 141B, 110–115.
   PubMed Web of Science ®Google Scholar
• DeLisi, L.E., Devoto, M., Lofthouse, R., Poulter, M., Smith, A., Shields, G., Bass, N., Chen, G., Vita, A., Morganti, C.,Ott, J., Crow, T.J. (1994). Search for linkage to schizophrenia on the X and Y chromosomes. American Journal of Medical Genetics, 54, 113–121.
   PubMed Web of Science ®Google Scholar
• Deshpande, S.N., Varma, P.G., Semwal, P., Rao, A.R., Bhatia, T., Nimgaonkar, V.L., Thelma, B.K. (2005). II Serotonin receptor gene polymorphisms and their association with tardive dyskinesia among schizophrenia patients from north India. Psychiatric Genetics, 15, 157–158.
   PubMed Web of Science ®Google Scholar
• Duan, J., Sanders, A.R. & Gejman, P.V. (2010). Genome-wide approaches to schizophrenia. Brain Research Bulletin, 83, 93–102.
   PubMed Web of Science ®Google Scholar
• Edwards, T.L., Wang, X., Chen, Q., Wormly, B., Riley, B., O'Neill, F.A., Chen, X. (2008). Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia. Schizophrenia Research, 106, 208–217.
   PubMed Web of Science ®Google Scholar
• Ellman, L.M., Yolken, R.H., Buka, S.L., Torrey, E.F. & Cannon, T.D. (2009). Cognitive functioning prior to the onset of psychosis: The role of fetal exposure to serologically determined influenza infection. Biological Psychiatry, 65, 1040–1047.
   PubMed Web of Science ®Google Scholar
• Fallin, M.D., Lasseter, V.K., Liu, Y., Avramopoulos, D., McGrath, J., Wolyniec, P.S., Pulver, A.E. (2011). Linkage and association on 8p21.2-p21.1 in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 156, 188–197.
   PubMedGoogle Scholar
• Feng, J. & Fan, G. (2009). The role of DNA methylation in the central nervous system and neuropsychiatric disorders. International Review of Neurobiology, 89, 67–84.
   PubMed Web of Science ®Google Scholar
• Ganguli, H.C. (2000). Epidemiological findings on prevalence of mental disorders in India. Indian Journal of Psychiatry, 42, 14–20.
   PubMedGoogle Scholar
• Gao, L.B., Zhong, S.R. & Jing, Q. (2010). Association of genetic polymorphisms of COMT gene with psychiatric disorders. Chinese Journal of Medical Genetics, 27, 650–653.
   Google Scholar
• Gasso, P., Mas, S., Alvarez, S., Trias, G., Bioque, M., Oliveira, C., Lafuente, A. (2010). Xenobiotic metabolizing and transporter genes: Gene–gene interactions in schizophrenia and related disorders. Pharmacogenomics, 11, 1725–1731.
   PubMed Web of Science ®Google Scholar
• Gejman, P.V., Sanders, A.R. & Duan, J. (2010). The role of genetics in the etiology of schizophrenia. Psychiatric Clinics of North America, 33, 35–66.
   PubMed Web of Science ®Google Scholar
• Gershon, E.S., Alliey-Rodriguez, N. & Liu, C. (2011). After GWAS: Searching for genetic risk for schizophrenia and bipolar disorder. American Journal of Psychiatry, 168, 253–256.
   PubMed Web of Science ®Google Scholar
• Girard, S.L., Gauthier, J., Noreau, A., Xiong, L., Zhou, S., Jouan, L., Rouleau, G.A. (2011). Increased exonic de novo mutation rate in individuals with schizophrenia. Nature Genetics, 43, 860–863.
   PubMed Web of Science ®Google Scholar
• Girirajan, S., Brkanac, Z., Coe, B.P., Baker, C., Vives, L., Vu, T.H., Eichler, E.E. (2011). Relative burden of large CNVs on a range of neurodevelopmental phenotypes. Public Library of Science Genetics, 7, e1002334.
   Google Scholar
• Glessner, J.T., Connolly, J.J. & Hakonarson, H. (2012). Rare genomic deletions and duplications and their role in neurodevelopmental disorders. Current Topics in Behavioral Neurosciences, 12, 345–360.
   PubMedGoogle Scholar
• Gottesman, I.I. (1994). Complications to the complex inheritance of schizophrenia. Clinical Genetics, 46, 116–123.
   PubMed Web of Science ®Google Scholar
• Gottesman, I.I. & Erlenmeyer-Kimling, L. (2001). Family and twin strategies as a head start in defining prodromes and endophenotypes for hypothetical early interventions in schizophrenia. Schizophrenia Research, 51, 93–102.
   PubMed Web of Science ®Google Scholar
• Gottesman, I.I. & Shields, J. (1967)A polygenic theory of schizophrenia. Proceedings of the National Academy of Sciences, 58, 199.
   PubMed Web of Science ®Google Scholar
• Gottesman, I.I. & Shields, J. (1982). Schizophrenia: The Epigenetic Puzzle. Cambridge: Cambridge University Press.
   Google Scholar
• Greenwood, T.A., Lazzeroni, L.C., Murray, S.S., Cadenhead, K.S., Calkins, M.E., Dobie, D.J., Braff, D.L. (2011). Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. American Journal of Psychiatry, 168, 930–946.
   PubMed Web of Science ®Google Scholar
• Grozeva, D., Conrad, D.F., Barnes, C.P., Hurles, M., Owen, M.J., O'Donovan, M.C., Kirov, G. (2012). Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia. Schizophrenia Research, 135, 1–7.
   PubMed Web of Science ®Google Scholar
• Guidotti, A., Auta, J., Chen, Y., Davis, J. M., Dong, E., Gavin, D. P., Tueting, P. (2010). Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology, 60, 1007–1016.
   PubMed Web of Science ®Google Scholar
• Guo, A.Y., Sun, J., Riley, B.P., Thiselton, D.L., Kendler, K.S. & Zhao, Z. (2009). The dystrobrevin-binding protein 1 gene: Features and networks. Molecular Psychiatry, 14, 18–29.
   PubMed Web of Science ®Google Scholar
• Gupta, M., Bhatnagar, P., Grover, S., Kaur, H., Baghel, R., Bhasin, Y., Kukreti, R. (2009a). Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment. Pharmacogenomics, 10, 385–397.
   PubMed Web of Science ®Google Scholar
• Gupta, M., Chauhan, C., Bhatnagar, P., Gupta, S., Grover, S., Singh, P.K., Kukreti, R. (2009b). Genetic susceptibility to schizophrenia: Role of dopaminergic pathway gene polymorphisms. Pharmacogenomics, 10, 277–291.
   PubMed Web of Science ®Google Scholar
• Gupta, M., Kaur, H., Jajodia, A., Jain, S., Satyamoorthy, K., Mukerji, M., Kukreti, R. (2011). Diverse facets of COMT: From a plausible predictive marker to a potential drug target for schizophrenia. Current Molecular Medicine, 11, 732–743.
   PubMed Web of Science ®Google Scholar
• Hamshere, M.L., Holmans, P.A., McCarthy, G.M., Jones, L.A., Murphy, K.C., Sanders, R.D., Cardno, A.G. (2011). Phenotype evaluation and genomewide linkage study of clinical variables in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 156B, 929–940.
   PubMed Web of Science ®Google Scholar
• Handoko, H.Y., Nancarrow, D.J., Hayward, N.K., Ohaeri, J.U., Aghanwa, H., McGrath, J.J., Mowry, B.J. (2003). Tumor necrosis factor haplotype analysis amongst schizophrenia probands from four distinct populations in the Asia-Pacific region. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 121B, 1–6.
   PubMed Web of Science ®Google Scholar
• Harrison, P.J. & Weinberger, D.R. (2005). Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Molecular Psychiatry, 10, 40–68.
   PubMed Web of Science ®Google Scholar
• Hayashi-Takagi, A. & Sawa, A. (2010). Disturbed synaptic connectivity in schizophrenia: Convergence of genetic risk factors during neurodevelopment. Brain Research Bulletin, 83, 140–146.
   PubMed Web of Science ®Google Scholar
• Holliday, E.G., Handoko, H.Y., James, M.R., McGrath, J.J., Nertney, D.A., Tirupati, S., Nyholt, D.R. (2006). Association study of the dystrobrevin-binding gene with schizophrenia in Australian and Indian samples. Twin Research and Human Genetics, 9, 531–539.
   PubMed Web of Science ®Google Scholar
• Holliday, E.G., Nyholt, D.R., Tirupati, S., John, S., Ramachandran, P., Ramamurti, M., Mowry, B.J. (2009). Strong evidence for a novel schizophrenia risk locus on chromosome 1p31.1 in homogeneous pedigrees from Tamil Nadu, India. American Journal of Psychiatry, 166, 206–215.
   PubMed Web of Science ®Google Scholar
• Hosak, L. (2007). Role of the COMT gene Val158Met polymorphism in mental disorders: A review. European Psychiatry, 22, 276–281.
   PubMed Web of Science ®Google Scholar
• Hunter, D.J. & Kraft, P. (2007). Drinking from the fire hose – Statistical issues in genomewide association studies. New England Journal of Medicine, 357, 436–439.
   PubMed Web of Science ®Google Scholar
• Insel, T.R. (2010). Rethinking schizophrenia. Nature, 468, 187–193.
   PubMed Web of Science ®Google Scholar
• International Schizophrenia Consortium (2008). Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature, 455, 237–241.
   PubMed Web of Science ®Google Scholar
• Jaaro-Peled, H., Hayashi-Takagi, A., Seshadri, S., Kamiya, A., Brandon, N.J. & Sawa, A. (2009). Neurodevelopmental mechanisms of schizophrenia: Understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends in Neurosciences, 32, 485–495.
   PubMed Web of Science ®Google Scholar
• Jia, P., Wang, L., Fanous, A.H., Chen, X., Kendler, K.S. & Zhao, Z. (2012). A bias-reducing pathway enrichment analysis of genome-wide association data confirmed association of the MHC region with schizophrenia. Journal of Medical Genetics, 49, 96–103.
   PubMed Web of Science ®Google Scholar
• Jia, P., Wang, L., Meltzer, H.Y. & Zhao, Z. (2010). Common variants conferring risk of schizophrenia: A pathway analysis of GWAS data. Schizophrenia Research, 122, 38–42.
   PubMed Web of Science ®Google Scholar
• Jones, A.L., Mowry, B.J., Pender, M.P. & Greer, J.M. (2005). Immune dysregulation and self-reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis?Immunology & Cell Biology, 83, 9–17.
   PubMed Web of Science ®Google Scholar
• Kendler, K.S. & Diehl, S.R. (1985). Schizophrenia: Genetics. Baltimore, MD: Williams & Wilkins.
   Google Scholar
• Kingsmore, S.F., Lindquist, I.E., Mudge, J., Gessler, D.D. & Beavis, W.D. (2008). Genome-wide association studies: Progress and potential for drug discovery and development. Nature Reviews Drug Discovery, 7, 221–230.
   PubMed Web of Science ®Google Scholar
• Kirov, G., Grozeva, D., Norton, N., Ivanov, D., Mantripragada, K.K., Holmans, P., O'Donovan, M.C. (2009). Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Human Molecular Genetics, 18, 1497–1503.
   PubMed Web of Science ®Google Scholar
• Kirov, G., Pocklington, A.J., Holmans, P., Ivanov, D., Ikeda, M., Ruderfer, D., Owen, M.J. (2012). De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Molecular Psychiatry, 17, 142–153.
   PubMed Web of Science ®Google Scholar
• Kukreti, R., Tripathi, S., Bhatnagar, P., Gupta, S., Chauhan, C., Kubendran, S., Brahmachari, S.K. (2006). Association of DRD2 gene variant with schizophrenia. Neuroscience Letters, 392, 68–71.
   PubMed Web of Science ®Google Scholar
• Kumarasinghe, N., Tooney, P. & Schall, U. (2012). Finding the needle in the haystack: A review of microarray gene expression research into schizophrenia. Australian and New Zealand Journal of Psychiatry, doi: 10.1177/0004867412442405.
   PubMed Web of Science ®Google Scholar
• Lang, U.E., Puls, I., Muller, D.J., Strutz-Seebohm, N. & Gallinat, J. (2007). Molecular mechanisms of schizophrenia. Cellular Physiology and Biochemistry, 20, 687–702.
   PubMed Web of Science ®Google Scholar
• Laruelle, M., Abi-Dargham, A., Gil, R., Kegeles, L., Innis, R. (1999). Increased dopamine transmission in schizophrenia: Relationship to illness phases. Biological Psychiatry, 46, 56–72.
   PubMed Web of Science ®Google Scholar
• Law, A.J., Lipska, B.K., Weickert, C.S., Hyde, T.M., Straub, R.E., Hashimoto, R., Weinberger, D.R. (2006). Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5’ SNPs associated with the disease. Proceedings of the National Academy of Sciences, 103, 6747–6752.
   PubMed Web of Science ®Google Scholar
• Levy, R.J., Xu, B., Gogos, J.A. & Karayiorgou, M. (2012). Copy number variation and psychiatric disease risk. Methods in Molecular Biology, 838, 97–113.
   PubMedGoogle Scholar
• Lewis, C.M., Levinson, D.F., Wise, L.H., DeLisi, L.E., Straub, R.E., Hovatta, I., Helgason, T. (2003). Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. American Journal of Human Genetics, 73, 34–48.
   PubMed Web of Science ®Google Scholar
• Li, M., Luo, X.J., Xiao, X., Shi, L., Liu, X.Y., Yin, L.D., Su, B. (2011). Analysis of common genetic variants identifies RELN as a risk gene for schizophrenia in Chinese population. World Journal of Biological Psychiatry, doi:10.3109/15622975.2011.587891.
   Web of Science ®Google Scholar
• Lieberman, J.A., Mailman, R.B., Duncan, G., Sikich, L., Chakos, M., Nichols, D.E., Kraus, J.E. (1998). Serotonergic basis of antipsychotic drug effects in schizophrenia. Biological Psychiatry, 44, 1099–1117.
   PubMed Web of Science ®Google Scholar
• Liou, Y.J., Bai, Y.M., Lin, E., Chen, J.Y., Chen, T.T., Hong, C.J. & Tsai, S.J. (2012). Gene–gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics. Pharmacogenomics Journal, 12, 54–61.
   PubMed Web of Science ®Google Scholar
• MacIntyre, D.J., Blackwood, D.H., Porteous, D.J., Pickard, B.S. & Muir, W.J. (2003). Chromosomal abnormalities and mental illness. Molecular Psychiatry, 8, 275–287.
   PubMed Web of Science ®Google Scholar
• Malhotra, D. & Sebat, J. (2012). CNVs: Harbingers of a rare variant revolution in psychiatric genetics. Cell, 148, 1223–1241.
   PubMed Web of Science ®Google Scholar
• Manolio, T.A. (2009a). Collaborative genome-wide association studies of diverse diseases: Programs of the NHGRI's office of population genomics. Pharmacogenomics, 10, 235–241.
   PubMed Web of Science ®Google Scholar
• Manolio, T.A., Collins, F.S., Cox, N.J., Goldstein, D.B., Hindorff, L.A., Hunter, D.J., Visscher, P.M. (2009b). Finding the missing heritability of complex diseases. Nature, 461, 747–753.
   PubMed Web of Science ®Google Scholar
• Maric, N.P. & Svrakic, D.M. (2012). Why schizophrenia genetics needs epigenetics: A review. Psychiatria Danubina, 24, 2–18.
   PubMed Web of Science ®Google Scholar
• McClellan, J. & King, M.C. (2010). Genomic analysis of mental illness: A changing landscape. Journal of the American Medical Association, 303, 2523–2524.
   PubMed Web of Science ®Google Scholar
• McGrath, J., Saha, S., Chant, D. & Welham, J. (2008). Schizophrenia: A concise overview of incidence, prevalence, and mortality. Epidemiologic Reviews, 30, 67–76.
   PubMed Web of Science ®Google Scholar
• Merikangas, K.R. & Risch, N. (2003). Will the genomics revolution revolutionize psychiatry?American Journal of Psychiatry, 160, 625–635.
   PubMed Web of Science ®Google Scholar
• Miuller, N. & Schwarz, M.J. (2007). The immunological basis of glutamatergic disturbance in schizophrenia: Towards an integrated view. Journal of Neural Transmission, Supplementum, 72, 269–280.
   Google Scholar
• Mudge, J., Miller, N.A., Khrebtukova, I., Lindquist, I.E., May, G.D., Huntley, J.J., Kingsmore, S.F. (2008). Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum. Public Library of Science One, 3, e3625.
   Google Scholar
• Narayan, P. & Dragunow, M. (2010). Pharmacology of epigenetics in brain disorders. British Journal of Pharmacology, 159, 285–303.
   PubMed Web of Science ®Google Scholar
• Nawa, H. & Takei, N. (2006). Recent progress in animal modeling of immune inflammatory processes in schizophrenia: Implication of specific cytokines. Neuroscience Research, 56, 2–13.
   PubMed Web of Science ®Google Scholar
• Ng, M.Y., Levinson, D.F., Faraone, S.V., Suarez, B.K., DeLisi, L.E., Arinami, T., Lewis, C.M. (2009). Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Molecular Psychiatry, 14, 774–785.
   PubMed Web of Science ®Google Scholar
• Nielsen, D.A., Virkkunen, M., Lappalainen, J., Eggert, M., Brown, G.L., Long, J.C., Linnoila, M. (1998). A tryptophan hydroxylase gene marker for suicidality and alcoholism. Archives of General Psychiatry, 55, 593–602.
   PubMed Web of Science ®Google Scholar
• O'Tuathaigh, C.M., Babovic, D., O'Sullivan, G.J., Clifford, J.J., Tighe, O., Croke, D.T., Waddington, J.L. (2007). Phenotypic characterization of spatial cognition and social behavior in mice with ‘knockout’ of the schizophrenia risk gene neuregulin 1. Neuroscience, 147, 18–27.
   PubMed Web of Science ®Google Scholar
• Opler, M.G. & Susser, E.S. (2005). Fetal environment and schizophrenia. Environmental Health Perspectives, 113, 1239–1242.
   PubMed Web of Science ®Google Scholar
• Pert, C.B., Knight, J.G., Laing, P. & Markwell, M.A. (1988). Scenarios for a viral etiology of schizophrenia. Schizophrenia Bulletin, 14, 243–247.
   PubMed Web of Science ®Google Scholar
• Poot, M., van der Smagt, J.J., Brilstra, E.H. & Bourgeron, T. (2011). Disentangling the myriad genomics of complex disorders, specifically focusing on autism, epilepsy, and schizophrenia. Cytogenetic and Genome Research, 135, 228–240.
   PubMed Web of Science ®Google Scholar
• Prasad, K.M., Bamne, M.N., Shirts, B.H., Goradia, D., Mannali, V., Pancholi, K.M., Nimgaonkar, V.L. (2010). Grey matter changes associated with host genetic variation and exposure to herpes simplex virus 1 (HSV1) in first episode schizophrenia. Schizophrenia Research, 118, 232–239.
   PubMed Web of Science ®Google Scholar
• Prasad, K.M., Eack, S.M., Goradia, D., Pancholi, K.M., Keshavan, M.S., Yolken, R.H. & Nimgaonkar, V.L. (2011). Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: A longitudinal study. American Journal of Psychiatry, 168, 822–830.
   PubMed Web of Science ®Google Scholar
• Prasad, K.M., Watson, A.M., Dickerson, F.B., Yolken, R.H. & Nimgaonkar, V.L. (2012). Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia. Schizophrenia Bulletin, doi: 10.1093/schbul/sbs046.
   Web of Science ®Google Scholar
• Prasad, S., Chowdari, K.V., Wood, J., Bhatia, T., Deshpande, S.N., Nimgaonkar, V.L. & Thelma, B.K. (2004). Association analysis of NOTCH 4 polymorphisms with schizophrenia among two independent family based samples. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 131B, 6–9.
   PubMed Web of Science ®Google Scholar
• Prasad, S., Deshpande, S.N., Bhatia, T., Wood, J., Nimgaonkar, V.L. & Thelma, B.K. (1999). Association study of schizophrenia among Indian families. American Journal of Medical Genetics, 88, 298–300.
   PubMed Web of Science ®Google Scholar
• Prasad, S., Semwal, P., Deshpande, S., Bhatia, T., Nimgaonkar, V.L. & Thelma, B.K. (2002). Molecular genetics of schizophrenia: Past, present and future. Journal of Biosciences, 27, 35–52.
   PubMed Web of Science ®Google Scholar
• Purcell, S.M., Wray, N.R., Stone, J.L., Visscher, P.M., O'Donovan, M.C., Sullivan, P.F. & Sklar, P. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460, 748–752.
   PubMed Web of Science ®Google Scholar
• Rapoport, J.L., Giedd, J.N. & Gogtay, N. (2012). Neurodevelopmental model of schizophrenia: Update 2012. Molecular Psychiatry, doi: 10.1038/mp.2012.23.
   Web of Science ®Google Scholar
• Rees, E., Kirov, G., O'Donovan, M.C. & Owen, M.J. (2012). De novo mutation in schizophrenia. Schizophrenia Bulletin, 38, 377–381.
   PubMed Web of Science ®Google Scholar
• Rees, E., Moskvina, V., Owen, M.J., O'Donovan, M.C. & Kirov, G. (2011). De novo rates and selection of schizophrenia-associated copy number variants. Biological Psychiatry, 70, 1109–1114.
   PubMed Web of Science ®Google Scholar
• Riley, B.P. & McGuffin, P. (2000). Linkage and associated studies of schizophrenia. American Journal of Medical Genetics, 97, 23–44.
   PubMed Web of Science ®Google Scholar
• Ripke, S., Sanders, A.R., Kendler, K.S., Levinson, D.F., Sklar, P., Holmans, P.A., Gejman, P.V. (2011). Genome-wide association study identifies five new schizophrenia loci. Nature Genetics, 43, 969–976.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Murillo, L., Gogos, J.A. & Karayiorgou, M. (2012). The genetic architecture of schizophrenia: New mutations and emerging paradigms. Annual Review of Medicine, 63, 63–80.
   PubMed Web of Science ®Google Scholar
• Roofeh, D., Tumuluru, D., Shilpakar, S. & Nimgaonkar, V.L. Genetics of schizophrenia: Where has the heritability gone? (unpublished manuscript).
   Google Scholar
• Rotondo, A., Schuebel, K., Bergen, A., Aragon, R., Virkkunen, M., Linnoila, M., Nielsen, D. (1999). Identification of four variants in the tryptophan hydroxylase promoter and association to behavior. Molecular Psychiatry, 4, 360–368.
   PubMed Web of Science ®Google Scholar
• Rudan, I. (2010). New technologies provide insights into genetic basis of psychiatric disorders and explain their co-morbidity. Psychiatria Danubina, 22, 190–192.
   PubMed Web of Science ®Google Scholar
• Saetre, P., Emilsson, L., Axelsson, E., Kreuger, J., Lindholm, E. & Jazin, E. (2007). Inflammation-related genes up-regulated in schizophrenia brains. BioMed Central Psychiatry, 7, 46.
   PubMedGoogle Scholar
• Saha, S., Chant, D., Welham, J. & McGrath, J. (2005). A systematic review of the prevalence of schizophrenia. Public Library of Science Medicine, 2, e141.
   Google Scholar
• Saleem, Q., Anand, A., Jain, S. & Brahmachari, S.K. (2001a). The polyglutamine motif is highly conserved at the Clock locus in various organisms and is not polymorphic in humans. Human Genetics, 109, 136–142.
   PubMed Web of Science ®Google Scholar
• Saleem, Q., Dash, D., Gandhi, C., Kishore, A., Benegal, V., Sherrin, T., Brahmachari, S.K. (2001b). Association of CAG repeat loci on chromosome 22 with schizophrenia and bipolar disorder. Molecular Psychiatry, 6, 694–700.
   PubMed Web of Science ®Google Scholar
• Saleem, Q., Sreevidya, V.S., Sudhir, J., Savithri, J.V., Gowda, Y., B-Rao, C., Benegal, V., Majumder, P.P., Anand, A., Brahmachari, S.K., Jain, S. (2000). Association analysis of CAG repeats at the KCNN3 locus in Indian patients with bipolar disorder and schizophrenia. American Journal of Medical Genetics, 96, 744–748.
   PubMedGoogle Scholar
• Sanders, A.R., Duan, J., Levinson, D.F., Shi, J., He, D., Hou, C., Gejman, P.V. (2008). No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: Implications for psychiatric genetics. American Journal of Psychiatry, 165, 497–506.
   PubMed Web of Science ®Google Scholar
• Sanders, S.J., Murtha, M.T., Gupta, A.R., Murdoch, J.D., Raubeson, M.J., Willsey, A.J., State, M.W. (2012). De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature, 485, 237–241.
   PubMed Web of Science ®Google Scholar
• Savage, R.M., Wiener, H.W., Nimgaonkar, V., Devlin, B., Calkins, M.E., Gur, R.E., Go, R.C. (2012). Heritability of functioning in families with schizophrenia in relation to neurocognition. Schizophrenia Research 139, 105–109. doi: 10.1016/j.schres. 2012.04.015.
   PubMed Web of Science ®Google Scholar
• Schijndel, J.E. & Martens, G.J. (2010). Gene expression profiling in rodent models for schizophrenia. Current Neuropharmacology, 8, 382–393.
   PubMed Web of Science ®Google Scholar
• Schubert, K.O., Focking, M., Prehn, J.H. & Cotter, D.R. (2011). Hypothesis review: Are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?Molecular Psychiatry, 17, 669–681.
   PubMed Web of Science ®Google Scholar
• Sebat, J., Levy, D.L. & McCarthy, S.E. (2009). Rare structural variants in schizophrenia: One disorder, multiple mutations; One mutation, multiple disorders. Trends in Genetics, 25, 528–535.
   PubMed Web of Science ®Google Scholar
• Seeman, P. (2010). Dopamine D2 receptors as treatment targets in schizophrenia. Clinical Schizophrenia and Related Psychoses, 4, 56–73.
   PubMedGoogle Scholar
• Semwal, P., Prasad, S., Bhatia, T., Deshpande, S.N., Wood, J., Nimgaonkar, V.L. & Thelma, B.K. (2001). Family-based association studies of monoaminergic gene polymorphisms among north Indians with schizophrenia. Molecular Psychiatry, 6, 220–224.
   PubMed Web of Science ®Google Scholar
• Semwal, P., Prasad, S., Varma, P.G., Bhagwat, A.M., Deshpande, S.N. & Thelma, B.K. (2002). Candidate gene polymorphisms among north Indians and their association with schizophrenia in a case-control study. Journal of Genetics, 81, 65–71.
   PubMed Web of Science ®Google Scholar
• Sequeira, P.A., Martin, M.V. & Vawter, M.P. (2012). The first decade and beyond of transcriptional profiling in schizophrenia. Neurobiology of Disease, 45, 23–36.
   PubMed Web of Science ®Google Scholar
• Shi, J., Levinson, D.F., Duan, J., Sanders, A.R., Zheng, Y., Pe'er, I., Gejman, P.V. (2009). Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature, 460, 753–757.
   PubMed Web of Science ®Google Scholar
• Shi, Y., Li, Z., Xu, Q., Wang, T., Li, T., Shen, J., He, L. (2011). Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. Nature Genetics, 43, 1224–1227.
   PubMed Web of Science ®Google Scholar
• Shirts, B.H., Kim, J.J., Reich, S., Dickerson, F.B., Yolken, R.H., Devlin, B. & Nimgaonkar, V.L. (2007). Polymorphisms in MICB are associated with human herpes virus seropositivity and schizophrenia risk. Schizophrenia Research, 94, 342–353.
   PubMed Web of Science ®Google Scholar
• Shirts, B.H., Wood, J., Yolken, R.H. & Nimgaonkar, V.L. (2006). Association study of IL10, IL1beta, and IL1RN and schizophrenia using tag SNPs from a comprehensive database: Suggestive association with rs16944 at IL1beta. Schizophrenia Research, 88, 235–244.
   PubMed Web of Science ®Google Scholar
• Singh, B., Bera, N.K., De, S., Nayak, C. & Chaudhuri, T.K. (2011). Study of HLA class I gene in Indian schizophrenic patients of Siliguri, West Bengal. Psychiatry Research, 189, 215–219.
   PubMed Web of Science ®Google Scholar
• Singh, B., Bera, N.K., Nayak, C.R. & Chaudhuri, T.K. (2009). Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients. Cytokine, 47, 1–5.
   PubMed Web of Science ®Google Scholar
• Smith, C.L., Bolton, A. & Nguyen, G. (2010). Genomic and epigenomic instability, fragile sites, schizophrenia and autism. Current Genomics, 11, 447–469.
   PubMed Web of Science ®Google Scholar
• Smrt, R.D., Szulwach, K.E., Pfeiffer, R.L., Li, X., Guo, W., Pathania, M., Zhao, X. (2010). MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells, 28, 1060–1070.
   PubMed Web of Science ®Google Scholar
• Srivastava, V., Deshpande, S.N. & Thelma, B.K. (2010). Dopaminergic pathway gene polymorphisms and genetic susceptibility to schizophrenia among north Indians. Neuropsychobiology, 61, 64–70.
   PubMed Web of Science ®Google Scholar
• Stefansson, H., Ophoff, R.A., Steinberg, S., Andreassen, O.A., Cichon, S., Rujescu, D., Collier, D.A. (2009). Common variants conferring risk of schizophrenia. Nature, 460, 744–747.
   PubMed Web of Science ®Google Scholar
• Stefansson, H., Rujescu, D., Cichon, S., Pietilainen, O.P., Ingason, A., Steinberg, S., Stefansson, K. (2008). Large recurrent microdeletions associated with schizophrenia. Nature, 455, 232–236.
   PubMed Web of Science ®Google Scholar
• Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Stefansson, K. (2002). Neuregulin 1 and susceptibility to schizophrenia. American Journal of Human Genetics, 71, 877–892.
   PubMed Web of Science ®Google Scholar
• Steinberg, S., de Jong, S., Andreassen, O.A., Werge, T., Borglum, A.D., Mors, O., Stefansson, K. (2011). Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Human Molecular Genetics, 20, 4076–4081.
   PubMed Web of Science ®Google Scholar
• Sugranyes, G., Kyriakopoulos, M., Corrigall, R., Taylor, E. & Frangou, S. (2011). Autism spectrum disorders and schizophrenia: Meta-analysis of the neural correlates of social cognition. Public Library of Science One, 6, e25322.
   Google Scholar
• Sullivan, P.F., Lin, D., Tzeng, J.Y., van den Oord, E., Perkins, D., Stroup, T.S., Close, S.L. (2008). Genomewide association for schizophrenia in the CATIE study: Results of stage 1. Molecular Psychiatry, 13, 570–584.
   PubMed Web of Science ®Google Scholar
• Sun, J., Jia, P., Fanous, A.H., van den Oord, E., Chen, X., Riley, B.P., Zhao, Z. (2010). Schizophrenia gene networks and pathways and their applications for novel candidate gene selection. Public Library of Science One, 5, e11351.
   Google Scholar
• Talkowski, M.E., Kirov, G., Bamne, M., Georgieva, L., Torres, G., Mansour, H., Nimgaonkar, V.L. (2008). A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Human Molecular Genetics, 17, 747–758.
   PubMed Web of Science ®Google Scholar
• Talkowski, M.E., Mansour, H., Chowdari, K.V., Wood, J., Butler, A., Varma, P.G., Nimgaonkar, V.L. (2006). Novel, replicated associations between dopamine D3 receptor gene polymorphisms and schizophrenia in two independent samples. Biological Psychiatry, 60, 570–577.
   PubMed Web of Science ®Google Scholar
• Tandon, R., Keshavan, M.S. & Nasrallah, H.A. (2008a). Schizophrenia, ‘just the facts’: What we know in 2008: Part 2. Epidemiology and etiology. Schizophrenia Research, 102, 1–18.
   PubMed Web of Science ®Google Scholar
• Tandon, R., Keshavan, M.S. & Nasrallah, H.A. (2008b). Schizophrenia, ‘just the facts’: What we know in 2008: Part 1: Overview. Schizophrenia Research, 100, 4–19.
   PubMed Web of Science ®Google Scholar
• Tang, B., Thornton-Wells, T. & Askland, K.D. (2011). Comparative linkage meta-analysis reveals regionally distinct, disparate genetic architectures: Application to bipolar disorder and schizophrenia. Public Library of Science One, 6, e19073.
   Google Scholar
• Taylor, S.F. & MacDonald, A.W. III. (2012). Brain mapping biomarkers of socio-emotional processing in schizophrenia. Schizophrenia Bulletin, 38, 73–80.
   PubMed Web of Science ®Google Scholar
• Torrey, E.F., Bartko, J.J. & Yolken, R.H. (2012). Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophrenia Bulletin, 38, 642–647.
   PubMed Web of Science ®Google Scholar
• Torrey, E.F., Leweke, M.F., Schwarz, M.J., Mueller, N., Bachmann, S., Schroeder, J., Yolken, R.H. (2006). Cytomegalovirus and schizophrenia. CNS Drugs, 20, 879–885.
   PubMed Web of Science ®Google Scholar
• Toyokawa, S., Uddin, M., Koenen, K.C. & Galea, S. (2012). How does the social environment ‘get into the mind’? Epigenetics at the intersection of social and psychiatric epidemiology. Social Science and Medicine, 74, 67–74.
   PubMed Web of Science ®Google Scholar
• Van Winkel, R., Esquivel, G., Kenis, G., Wichers, M., Collip, D., Peerbooms, O., Van Os, J. (2010). REVIEW: Genome-wide findings in schizophrenia and the role of gene–environment interplay. CNS Neuroscience and Therapeutics, 16, e185–192.
   PubMed Web of Science ®Google Scholar
• Vawter, M.P., Barrett, T., Cheadle, C., Sokolov, B.P., Wood, W.H. III, Donovan, D.M., Becker, K.G. (2001). Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Research Bulletin, 55, 641–650.
   PubMed Web of Science ®Google Scholar
• Vereczkei, A. & Mirnics, K. (2011). Genetic predisposition to schizophrenia: What did we learn and what does the future hold?Neuropsychopharmacol Hung, 13, 205–210.
   PubMedGoogle Scholar
• Verma, R., Chauhan, C., Saleem, Q., Gandhi, C., Jain, S. & Brahmachari, S.K. (2004). A nonsense mutation in the synaptogyrin 1 gene in a family with schizophrenia. Biological Psychiatry, 55, 196–199.
   PubMed Web of Science ®Google Scholar
• Verma, R., Kubendran, S., Das, S.K., Jain, S. & Brahmachari, S.K. (2005a). SYNGR1 is associated with schizophrenia and bipolar disorder in southern India. Journal of Human Genetics, 50, 635–640.
   PubMed Web of Science ®Google Scholar
• Verma, R., Mukerji, M., Grover, D., B-Rao, C., Das, S.K., Kubendran, S., Brahmachari, S.K. (2005b). MLC1 gene is associated with schizophrenia and bipolar disorder in southern India. Biological Psychiatry, 58, 16–22.
   PubMed Web of Science ®Google Scholar
• Vijayan, N.N., Bhaskaran, S., Koshy, L.V., Natarajan, C., Srinivas, L., Nair, C.M., Banerjee, M. (2007). Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a south Indian population. Behavioral and Brain Functions, 3, 34.
   PubMed Web of Science ®Google Scholar
• Vijayan, N.N., Iwayama, Y., Koshy, L.V., Natarajan, C., Nair, C., Allencherry, P.M., Banerjee, M. (2009). Evidence of association of serotonin transporter gene polymorphisms with schizophrenia in a south Indian population. Journal of Human Genetics, 54, 538–542.
   PubMed Web of Science ®Google Scholar
• Waddington, J.L., Corvin, A.P., Donohoe, G., O'Tuathaigh, C.M., Mitchell, K.J. & Gill, M. (2007). Functional genomics and schizophrenia: Endophenotypes and mutant models. Psychiatric Clinics of North America, 30, 365–399.
   PubMed Web of Science ®Google Scholar
• Weinberger, D.R. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry, 44, 660–669.
   PubMed Web of Science ®Google Scholar
• Wellcome Trust Case Control Consortium (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447, 661–678.
   PubMed Web of Science ®Google Scholar
• Wiener, H., Klei, L., Calkins, M., Wood, J., Nimgaonkar, V., Gur, R., Go, R. (2012). Principal components of heritability from neurocognitive domains differ between families with schizophrenia and control subjects. Schizophrenia Bulletin,doi: 10.1093/schbul/sbr161.
   PubMed Web of Science ®Google Scholar
• Williams, H.J., Norton, N., Dwyer, S., Moskvina, V., Nikolov, I., Carroll, L., O'Donovan, M.C. (2010). Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Molecular Psychiatry, 16, 429–441.
   PubMed Web of Science ®Google Scholar
• Williams, N.M., O'Donovan, M.C. & Owen, M.J. (2006). Chromosome 22 deletion syndrome and schizophrenia. International Review of Neurobiology, 73, 1–27.
   PubMed Web of Science ®Google Scholar
• Woelk, C.H., Singhania, A., Perez-Santiago, J., Glatt, S.J. & Tsuang, M.T. (2011). The utility of gene expression in blood cells for diagnosing neuropsychiatric disorders. International Review of Neurobiology, 101, 41–63.
   PubMed Web of Science ®Google Scholar
• Wright, P., Nimgaonkar, V.L., Donaldson, P.T. & Murray, R.M. (2001). Schizophrenia and HLA: A review. Schizophrenia Research, 47, 1–12.
   PubMed Web of Science ®Google Scholar
• Xu, B., Roos, J.L., Dexheimer, P., Boone, B., Plummer, B., Levy, S., Karayiorgou, M. (2011). Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nature Genetics, 43, 864–868.
   PubMed Web of Science ®Google Scholar
• Yamada, K., Iwayama, Y., Hattori, E., Iwamoto, K., Toyota, T., Ohnishi, T., Yoshikawa, T. (2011). Genome-wide association study of schizophrenia in Japanese population. Public Library of Science One, 6, e20468.
   Google Scholar
• Yi, Z., Zhang, C., Lu, W., Song, L., Liu, D., Xu, Y. & Fang, Y. (2012). Common variants in the TPH2 promoter confer susceptibility to paranoid schizophrenia. Journal of Molecular Neuroscience, 47, 465–469.
   PubMed Web of Science ®Google Scholar
• Yolken, R.H. & Torrey, E.F. (2008). Are some cases of psychosis caused by microbial agents?A review of the evidence. Molecular Psychiatry, 13, 470–479.
   PubMed Web of Science ®Google Scholar
• Yue, W.H., Wang, H.F., Sun, L.D., Tang, F.L., Liu, Z.H., Zhang, H.X., Zhang, D. (2011). Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. Nature Genetics, 43, 1228–1231.
   PubMed Web of Science ®Google Scholar
• Zahir, F.R. & Brown, C.J. (2011). Epigenetic impacts on neurodevelopment: pathophysiological mechanisms and genetic modes of action. Pediatric Research, 69, 92R–100R.
   Web of Science ®Google Scholar
• Zhang, J.P. & Malhotra, A.K. (2011). Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction. Expert Opinion on Drug Metabolism & Toxicology, 7, 9–37.
   Google Scholar
• Zhao, Q., Li, T., Zhao, X., Huang, K., Wang, T., Li, Z., Shi, Y. (2012). Rare CNVs and tag SNPs at 15q11.2 are associated with schizophrenia in the Han Chinese population. Schizophrenia Bulletin, doi: 10.1093/schbul/sbr197.
   PubMed Web of Science ®Google Scholar